BioSpace News Archive

Business

Orthofix Reports Second Quarter 2018 Financial Results

Second Quarter Highlights

August 6, 2018
·
23 min read
Business

Diplomat Announces 2nd Quarter Financial Results

2nd Quarter Revenue of $1,416 Million, an increase of 26%, Net (Loss) Income Attributable to Diplomat of $(4.0) Million compared to $3.6 Million, Adjusted EBITDA of $42.7 Million, an increase of 70%

August 6, 2018
·
49 min read
Business

Jazz Pharmaceuticals and MD Anderson Cancer Center Collaborate to Evaluate Potential Treatment Options for Hematologic Malignancies

Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) and The University of Texas MD Anderson Cancer Center today announced a five-year collaboration agreement with a goal of evaluating therapies for multiple hematologic malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndromes.

August 6, 2018
·
7 min read
BioMidwest

Teledyne ISCO Announces Update to Popular CombiFlash Line of Flash Chromatography Systems

CombiFlash NextGen’s Three New Models Offer Smaller Footprint and Greener Use

August 6, 2018
·
3 min read
Deals

Rite Aid and Albertsons Announce Deadline for Election of Form of Consideration

Rite Aid Corporation and Albertsons Companies, Inc. announced that, in connection with the pending merger between Albertsons and Rite Aid, the election deadline for holders of shares of Rite Aid common stock is 5:00 p.m. Eastern Time on August 13, 2018.

August 6, 2018
·
9 min read
Drug Development

amcure Announces First Patient Dosed with AMC303 in Phase Ib Extension Cohort Based on Positive Safety Results

Top-line Results of Dose-Escalation Part to be Presented at ESMO 2018 Congress

August 6, 2018
·
3 min read
FDA

U.S. FDA Grants Fast Track Designation for BioCryst’s BCX7353

BioCryst Pharmaceuticals, Inc. announced that the Company has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for BCX7353 for the prevention of angioedema attacks in patients with hereditary angioedema (HAE).

August 6, 2018
·
3 min read
Business

Regeneron and bluebird bio Announce Collaboration to Discover, Develop and Commercialize New Cell Therapies for Cancer

Regeneron Pharmaceuticals, Inc. and bluebird bio, Inc. announced a collaboration to apply their respective technology platforms to the discovery, development and commercialization of novel immune cell therapies for cancer.

August 6, 2018
·
11 min read
FDA

Elite Pharmaceuticals Receives FDA Approval for Generic Methadone Hydrochloride Tablets

Methadone is indicated for the management of pain severe enough to require daily, around-the-clock long-term opioid treatment and for which alternative treatment options are inadequate.

August 6, 2018
·
3 min read
Business

Cardinal Health Reports Fourth-quarter and Year-end Results for Fiscal Year 2018

Fourth-quarter revenue increased 7 percent to $35 billion; full-year revenue increased 5 percent to $137 billion

August 6, 2018
·
54 min read